Skip to main content
Livermore
Livermore
ZHEN

DnB Asset Management AS

SEC CIK
0001456670
Latest filing
Aug 11, 2026

RPRX holding history

Royalty Pharma plc in every 13F filed by DnB Asset Management AS, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RPRX overviewAll 13F holders of RPRXFull Q2 2026 holdings

Shares (Q2 2026)
130,008
Value
$7.29M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RPRX by DnB Asset Management AS, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026130,008$7.29M<0.1%+37,943+41.2%AddedHolders
Q1 202692,065$4.42M<0.1%+2,390+2.7%AddedHolders
Q4 202589,675$3.47M<0.1%+7,374+9.0%AddedHolders
Q3 202582,301$2.90M<0.1%+5,466+7.1%AddedHolders
Q2 202576,835$2.77M<0.1%+9,381+13.9%AddedHolders
Q1 202567,454$2.10M<0.1%−3,652−5.1%ReducedHolders
Q4 202471,106$1.81M<0.1%+3,033+4.5%AddedHolders
Q3 202468,073$1.93M<0.1%−3,244−4.5%ReducedHolders
Q2 202471,317$1.88M<0.1%+14,042+24.5%AddedHolders
Q1 202457,275$1.74M<0.1%−43,631−43.2%ReducedHolders
Q4 2023100,906$2.83M<0.1%−778−0.8%ReducedHolders
Q3 2023101,684$2.76M<0.1%+10,629+11.7%AddedHolders
Q2 202391,055$2.80M<0.1%+11,527+14.5%AddedHolders
Q1 202379,528$2.87M<0.1%+21,236+36.4%AddedHolders
Q4 202258,292$2.30M<0.1%+317+0.5%AddedHolders
Q3 202257,975$2.33M<0.1%00.0%UnchangedHolders
Q2 202257,975$2.44M<0.1%−9,593−14.2%ReducedHolders
Q1 202267,568$2.63M<0.1%+2,869+4.4%AddedHolders
Q4 202164,699$2.58M<0.1%+45,973+245.5%AddedHolders
Q3 202118,726$676.8K<0.1%00.0%UnchangedHolders
Q2 202118,726$767.6K<0.1%+2,800+17.6%AddedHolders
Q1 202115,926$694.7K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.